Acalabrutinib 100mg Tablet contains acalabrutinib, a Bruton tyrosine kinase (BTK) inhibitor used for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and selected mantle cell lymphoma (MCL) indications depending on the local approval. Generic acalabrutinib contains the same active ingredient as Calquence® 100mg, while manufacturer, excipients and packaging may differ. Current market terminology also includes Calquence 100 mg comprimés pelliculés, Acalabrutinib 100 mg Filmtabletten, 아칼라브루티닙 100mg and акалабрутиниб 100 мг.
Acalabrutinib 100mg is used in approved treatment settings for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and for certain adult mantle cell lymphoma (MCL) indications. U.S., UK, Australian and other national labels differ in the exact treatment setting and combinations allowed.
Acalabrutinib 100mg is the active ingredient in Calquence®. Generic products are marketed by different manufacturers and can have different packaging, inactive ingredients and physical appearance. The exact product should always be matched to the relevant national authorization and prescription requirements.
Acalabrutinib selectively inhibits BTK, a protein involved in B-cell receptor signaling. Blocking BTK can interfere with signaling that supports the growth and survival of malignant B cells.
Acalabrutinib treatment requires specialist supervision. Important labeled risks include serious infections, bleeding, reduced blood cell counts, cardiac arrhythmias, liver injury and second primary malignancies. Drug interactions, particularly involving CYP3A medicines, also require attention.
Searches for Acalabrutinib 100mg Tablet, Calquence 100mg, generic Calquence 100mg, acalabrutinib price, acalabrutinib tablets and acalabrutinib for CLL are relevant to this product category. Supply of prescription oncology medicines should follow the prescribing, pharmacy and import requirements applicable to the destination country.
What is Acalabrutinib 100mg used for?
It is used for approved treatment of CLL/SLL and selected MCL indications in adults.
Is Acalabrutinib the generic name for Calquence?
Yes. Calquence® is a brand containing the active ingredient acalabrutinib.
Is Acalabrutinib a BTK inhibitor?
Yes. Acalabrutinib is a selective Bruton tyrosine kinase inhibitor.
Is Acalabrutinib 100mg a tablet?
Yes. Current U.S., UK, Australian and French Calquence presentations include 100mg tablets, while some markets also have capsule presentations.
Is Acalabrutinib prescription-only?
It is a prescription oncology medicine in the markets referenced here; exact regulatory requirements vary by country.
Last Updated: September 26, 2026 | Medically Reviewed By: Licensed Pharmacist
Medical Disclaimer:
This information is for educational and product-identification purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Acalabrutinib should be used only under appropriate specialist supervision.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Satyajit Hota –
milanmedicals.com best online cancer medical
Abhishek Babel –
Order for father. Delivered in two days. thanks
Dekou Komla Vinyo Senyo –
Nice experice. Easy payment fast delivery to Togo Africa.
Vasudevan –
NEXT DAY DELIVERY IN TAMIL NADU. FREE HOME DELIVERY
Varshini –
thnaks
Satendra KUMAR –
Quality Delivery for cancer medicine acabrunat 100 mg
Kulpreet Singh –
Gjb service. easy to place order. Best online price